These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 18450844)

  • 1. Acute effects of alcohol septal ablation on systolic and diastolic left ventricular function in patients with hypertrophic obstructive cardiomyopathy.
    Steendijk P; Meliga E; Valgimigli M; Ten Cate FJ; Serruys PW
    Heart; 2008 Oct; 94(10):1318-22. PubMed ID: 18450844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy on systolic and diastolic left ventricular function assessed by pressure-volume loops.
    Meliga E; Steendijk P; Valgimigli M; Ten Cate FJ; Serruys PW
    Am J Cardiol; 2008 Apr; 101(8):1179-84. PubMed ID: 18394455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
    Krejcí J; Groch L; Meluzín J; Vykypel T; Halámek J; Vitovec J
    Vnitr Lek; 2006 Apr; 52(4):313-20. PubMed ID: 16755987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis.
    van Dockum WG; Kuijer JP; Götte MJ; Ten Cate FJ; Ten Berg JM; Beek AM; Twisk JW; Marcus JT; Visser CA; van Rossum AC
    Eur Heart J; 2006 Dec; 27(23):2833-9. PubMed ID: 17098761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome.
    Veselka J; Procházková S; Duchonová R; Bolomová-Homolová I; Pálenícková J; Tesar D; Cervinka P; Honek T
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):231-5. PubMed ID: 15390343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
    Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
    Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
    Matsubara H; Nakatani S; Nagata S; Ishikura F; Katagiri Y; Ohe T; Miyatake K
    J Am Coll Cardiol; 1995 Sep; 26(3):768-75. PubMed ID: 7642872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical ventricular restoration in patients with ischemic dilated cardiomyopathy: evaluation of systolic and diastolic ventricular function, wall stress, dyssynchrony, and mechanical efficiency by pressure-volume loops.
    Tulner SA; Steendijk P; Klautz RJ; Bax JJ; Schalij MJ; van der Wall EE; Dion RA
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):610-20. PubMed ID: 16935117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of the treatment of the nodal reentrant tachycardia by RF catheter ablation on selected hemodynamic parameters of left ventricular systolic and diastolic function and exercise capacity].
    Lelakowski J; Dreher A
    Pol Merkur Lekarski; 2009 Jun; 26(156):600-4. PubMed ID: 19711724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac electromechanical mapping in analyzing the mechanism of left ventricular remodeling immediately after percutaneous transluminal septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Chen SL; Huang J; Ye F; Shan SJ; Zhang JJ; Duan BX; Chen YD
    Chin Med J (Engl); 2005 Nov; 118(21):1779-85. PubMed ID: 16336814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of successful alcohol septal ablation on microvascular function in patients with obstructive hypertrophic cardiomyopathy.
    Soliman OI; Geleijnse ML; Michels M; Dijkmans PA; Nemes A; van Dalen BM; Vletter WB; Serruys PW; ten Cate FJ
    Am J Cardiol; 2008 May; 101(9):1321-7. PubMed ID: 18435965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular isovolumic relaxation is a predictor of left ventricular end-diastolic pressure.
    Detsky ME; Azevedo ER; Parker JD
    Can J Cardiol; 2003 Mar; 19(4):378-82. PubMed ID: 12704482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of left ventricular chamber stiffness at rest to exercise capacity in hypertrophic cardiomyopathy.
    Dumont CA; Monserrat L; Peteiro J; Soler R; Rodriguez E; Bouzas A; Fernández X; Pérez R; Bouzas B; Castro-Beiras A
    Am J Cardiol; 2007 May; 99(10):1454-7. PubMed ID: 17493479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure.
    Baicu CF; Zile MR; Aurigemma GP; Gaasch WH
    Circulation; 2005 May; 111(18):2306-12. PubMed ID: 15851588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets.
    van der Lee C; ten Cate FJ; Geleijnse ML; Kofflard MJ; Pedone C; van Herwerden LA; Biagini E; Vletter WB; Serruys PW
    Circulation; 2005 Jul; 112(4):482-8. PubMed ID: 16027255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immediate hemodynamic response to atrioventricular+ stimulation in severe hypertrophic obstructive myocardiopathy].
    Tascón Pérez JC; Albarrán A; Trevilla G; Alonso Gutiérrez M; Andreu Dussac J; Lombera Romero F; Escribano Subías P; Hernández Afonso J; Hernández Hernández F; Coma Samartín R; Rodríguez García J; García Cosío F
    Rev Esp Cardiol; 1996 Nov; 49(11):815-22. PubMed ID: 9082492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a Scandinavian multicenter study.
    Jensen MK; Almaas VM; Jacobsson L; Hansen PR; Havndrup O; Aakhus S; Svane B; Hansen TF; Køber L; Endresen K; Eriksson MJ; Jørgensen E; Amlie JP; Gadler F; Bundgaard H
    Circ Cardiovasc Interv; 2011 Jun; 4(3):256-65. PubMed ID: 21540441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Percutaneous transluminal ablation of the myocardial septum by embolization of the first branch of the anterior descending coronary artery using a small amount of absolute alcohol].
    Miric M; Sagic D; Popovic Z; Zlatanovic M; Vlahovic A; Vidakovic R; Bojic M
    Srp Arh Celok Lek; 2001; 129(7-8):199-202. PubMed ID: 11797450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic changes in percutaneous transluminal septal coil embolization for hypertrophic obstructive cardiomyopathy.
    Ramcharitar S; Meliga E; Kirschbaum SW; ten Cate FJ; van Geuns RJ; Serruys PW
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):806-10. PubMed ID: 18838967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathophysiology of hypertrophic and congestive cardiomyopathies: a guide of fundamental therapeutic approach (author's transl)].
    Hirota Y; Shimizu G; Kaku K; Furubayashi K; Kawamura K; Takatsu T
    J Cardiogr; 1981 Dec; 11(4):1127-46. PubMed ID: 7201493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.